Statistics for Ivermectin shows clinical benefits in mild to moderate COVID-19: A randomised controlled double-blind dose-response study in Lagos.
Total visits
| views | |
|---|---|
| Ivermectin shows clinical benefits in mild to moderate COVID-19: A randomised controlled double-blind dose-response study in Lagos. | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Abstract QJM.docx | 3 |